Zoledronate and Raloxifene combination therapy enhances material and mechanical properties of diseased mouse bone

Current interventions to reduce skeletal fragility are insufficient at enhancing both the quantity and quality of bone when attempting to improve overall mechanical integrity. Bisphosphonates, such as Zoledronate (ZOL), are used to treat a variety of bone disorders by increasing bone mass to decreas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Bone
Asıl Yazarlar: Powell, Katherine M., Skaggs, Cayla, Pulliam, Alexis, Berman, Alycia, Allen, Matthew R., Wallace, Joseph M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7036744/
https://ncbi.nlm.nih.gov/pubmed/31233931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2019.06.018
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller